Skip to content

The clinical trials on the effectiveness and safety of the THROMBOCHECK for testing the function of Bileaflet Mechanical Heart Valve in patients

The clinical trials on the effectiveness and safety of the THROMBOCHECK for testing the function of Bileaflet Mechanical Heart Valve in patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079511
Enrollment
Unknown
Registered
2024-01-04
Start date
2023-12-26
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the function of Bileaflet Mechanical Heart Valve in patients

Interventions

Gold Standard:The clinical diagnosis results obtained from the same subject undergoing transthoracic echocardiography (+transesophageal echocardiography or cardiac CT) examination
Generally, when the image quality of transthoracic echocardiography is unclear, difficult to identify, and cannot be clearly diagnosed clinically, subjects need to undergo transesophageal echocardiogr
Only when there is a clear clinical diagnosis on transthoracic echocardiography, but the examination results are inconsistent with those of mechanical heart valve detectors
Index test:Mechanical Heart Valve Tester (TC-2, Xiongzhi Medical Equipment Technology (Suzhou) Co., Ltd.)

Sponsors

Beijing Anzhen Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age = 18 years old, regardless of gender; (2) Implant 1-2 Bileaflet Mechanical Heart Valves subjects; (3) The subjects or their guardians are able to understand the research purpose, demonstrate sufficient compliance with the research protocol, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who have implanted a single leaflet valve; (2) Patients with severe infections, allergies, scars, or skin diseases on the skin of the precordial region; (3) Patients who require support from mechanical noise equipment such as ventilators; (4) Patients with implantation of two leaflets and arrhythmia; (5) The subjects are pregnant or lactating women; (6) Participated in clinical trials of other intervention drugs, biologics, or devices within one month prior to screening; (7) Other situations that the researcher determines are not suitable for selection.

Design outcomes

Primary

MeasureTime frame
The total coincidence rate;

Secondary

MeasureTime frame
Sensitivity;Specificity;Kappa;Positive predictive value;Negative predictive value;Satisfaction evaluation;Adverse event occurrence rate;Serious adverse event incidence rate;Medical device defect incidence rate;

Countries

China

Contacts

Public ContactHaibo Zhang

Beijing Anzhen Hospital Affiliated to Capital Medical University

Zhanghb2318@163.com+86 133 7010 3561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026